Clinical trial · Observational
Study of the Influence of Ductal Carcinoma in Situ on the Outcome of Invasive Breast Cancer
Longitudinal Observational Study About the Influence of Ductal Carcinoma in Situ on the Outcome of Invasive Breast Cancer
NCT03669952CI-TRIAL-00034897completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A prospective observational longitudinal study of 464 patients was performed between 2010 and 2015. Patients with invasive ductal carcinoma (IDC) and ductal carcinoma in situ associated to invasive ductal carcinoma (DCIS +IDC) were included and analyzed.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Outcome of Breast Cancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| None intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Invasive ductal carcinoma
- description
- Patients with Invasive ductal carcinoma
- interventionNames
- Other: None intervention
Primary outcomes (1)
- measure
- Recurrence
- timeFrame
- Patients included between 2010 and 2015 will be follow up til January of 2018 with a mean follow up of 51.43 months
- description
- Neoplasm metastasis, either local or distant recurrence of the invasive ductal carcinoma
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients with invasive ductal carcinoma of the breast * Patients who received surgery for primary invasive breast cancer between 2010 and 2015 Exclusion Criteria: * Patients with metastasis at the diagnostic
References
Publications (0)
Data not yet available
No reference posted for this study.